A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene

Richard H. Duerr(Cedars-Sinai Medical Center), Kent D. Taylor(Cedars-Sinai Medical Center), Steven R. Brant(Cedars-Sinai Medical Center), John D. Rioux(Cedars-Sinai Medical Center), Mark S. Silverberg(Cedars-Sinai Medical Center), Mark J. Daly(Cedars-Sinai Medical Center), A. Hillary Steinhart(Cedars-Sinai Medical Center), Clara Abraham(Cedars-Sinai Medical Center), Miguel Regueiro(Cedars-Sinai Medical Center), Anne M. Griffiths(Cedars-Sinai Medical Center), Themistocles Dassopoulos(Cedars-Sinai Medical Center), Alain Bitton(Cedars-Sinai Medical Center), Huiying Yang(Cedars-Sinai Medical Center), Stephan R. Targan(Cedars-Sinai Medical Center), Lisa W. Datta(Cedars-Sinai Medical Center), Emily O. Kistner(Cedars-Sinai Medical Center), L. Philip Schumm(Cedars-Sinai Medical Center), Annette T. Lee(Cedars-Sinai Medical Center), Peter K. Gregersen(Cedars-Sinai Medical Center), M. Michael Barmada(Cedars-Sinai Medical Center), Jerome I. Rotter(Cedars-Sinai Medical Center), Dan L. Nicolae(Cedars-Sinai Medical Center), Judy H. Cho(Cedars-Sinai Medical Center)
Science
October 26, 2006
Cited by 2,989Open Access
Full Text

Abstract

The inflammatory bowel diseases Crohn's disease and ulcerative colitis are common, chronic disorders that cause abdominal pain, diarrhea, and gastrointestinal bleeding. To identify genetic factors that might contribute to these disorders, we performed a genome-wide association study. We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23. An uncommon coding variant (rs11209026, c.1142G>A, p.Arg381Gln) confers strong protection against Crohn's disease, and additional noncoding IL23R variants are independently associated. Replication studies confirmed IL23R associations in independent cohorts of patients with Crohn's disease or ulcerative colitis. These results and previous studies on the proinflammatory role of IL-23 prioritize this signaling pathway as a therapeutic target in inflammatory bowel disease.


Related Papers

No related papers found

Powered by citation graph analysis